share_log

Milestone Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Duty Stuart

SEC ·  Jul 18, 2024 04:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more